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Abstract
It is well-known that fibroblasts play a fundamental role in the contraction of collagen
and fibrin hydrogels when used in the production of in vitro bilayered skin substi-
tutes. However, little is known about the contribution of other factors, such as the
hydrogel matrix itself, on this contraction. In this work, we studied the contraction of
plasma-derived fibrin hydrogels at different temperatures (4, 23, and 37C) in an iso-
tonic buffer (phosphate-buffered saline). These types of hydrogels presented a con-
traction of approximately 30% during the first 24 hr, following a similar kinetics
irrespectively of the temperature. This kinetics continued in a slowed down manner
to reach a plateau value of 40% contraction after 10–15 days. Contraction of com-
mercial fibrinogen hydrogels was studied under similar conditions and the kinetics
was completed after 8 hr, reaching values between 20 and 70% depending on the
temperature. We attribute these substantial differences to a modulatory effect on
the contraction due to plasma proteins which are initially embedded in, and progres-
sively released from, the plasma-based hydrogels. The elastic modulus of hydrogels
measured at a constant frequency decreased with increasing temperature in 7-day
gels. Rheological measurements showed the absence of a strain-hardening behavior
in the plasma-derived fibrin hydrogels. Finally, plasma-derived fibrin hydrogels with
and without human primary fibroblast and keratinocytes were prepared in transwell
inserts and their height measured over time. Both cellular and acellular gels showed a
height reduction of 30% during the first 24 hr likely due to the above-mentioned
intrinsic fibrin matrix contraction.
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1 | INTRODUCTION
Over the last years, there has been a huge demand in the develop-
ment and production of in vitro-engineered skin substitutes that
mimic human skin, either to be used as grafts to restore the damaged
skin or for the establishment of human-based in vitro skin models for
toxicity, cosmetic, and pharmaceutical testing (Chua et al., 2016;
Groeber, Holeiter, Hampel, Hinderer, & Schenke-Layland, 2011; Mac-
Neil, 2007; Mathes, Ruffner, & Graf-Hausner, 2014; Metcalfe & Fer-
guson, 2007; Shevchenko, James, & James, 2010; Shores, Gabriel, &
Gupta, 2007; Supp & Boyce, 2005; Vig et al., 2017). As a result, acellu-
lar and cellular skin substitutes (containing keratinocytes, fibroblasts
and adipocytes) as cellular monolayers (epidermal substitutes), cellular
bilayers (dermoepidermal substitutes) and cellular trilayers
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(dermoepidermal–hypodermal substitutes) skin substitutes have been
explored in this field (Auger, Lacroix, & Germain, 2009; Stojic
et al., 2019; Vig et al., 2017; Yu et al., 2019).
Cellular bilayered constructs containing dermal and epidermal
components offer a promising approach to skin engineering since they
allow the preparation of more sophisticated laboratory-grown skin
substitutes which better resemble the structure and function of
human skin (Caravaggi et al., 2003; Centanni et al., 2011; Curran &
Plosker, 2002; Llames et al., 2004; Llames et al., 2006; Meana
et al., 1998; Stark et al., 2006; Still, Glat, Silverstein, Griswold, &
Mozingo, 2003). The production of bilayered artificial human skin usu-
ally involves the use of different types of scaffolds composed of natu-
ral (such as alginate, collagen, chitosan, fibrin and hyaluronic acid)
and/or synthetic (such as poly(ethylene glycol), polycaprolactone, poly
(vinyl alcohol), polylactic acid, and poly-L-lactic acid (Chaudhari
et al., 2016; Jeong, Park, & Lee, 2017; MacNeil, 2008; Norouzi, Bor-
oujeni, Omidvarkordshouli, & Soleimani, 2015; Priya, Jungvid, &
Kumar, 2008). Among them, collagen (the main component in the
extracellular matrix [ECM]) and fibrin (derived from blood fibrinogen)
hydrogels have been used extensively to provide structural and
mechanical support (Ahmed, Dare, & Hincke, 2008; Cen, Liu, Cui,
Zhang, & Cao, 2008; Glowacki & Mizuno, 2008).
As an example of production of human artificial skin, our lab has
engineered a human plasma-derived bilayered skin substitute con-
taining primary human fibroblasts (hFBs) and keratinocytes (hKCs)
from skin biopsies (Meana et al., 1998). These bilayered skin grafts
have been successfully used to treat burns, as well as traumatic and
surgical wounds in a large number of patients in Spain and for the
generation of skin-humanized mouse models (Guerrero-Aspizua
et al., 2010; Llames et al., 2004; Llames et al., 2006; Martinez-
Santamaria et al., 2013). Our lab has also developed a complete sys-
tem (printer and bioinks) to 3D print this bilayered skin for clinical and
commercial testing purposes (Cubo, Garcia, del Canizo, Velasco, &
Jorcano, 2016; Velasco, Quílez, Garcia, del Cañizo, & Jorcano, 2018).
In general, these skin substitutes formed by two layers, representing
the dermis and the epidermis, were generated following the method
developed in (Meana et al., 1998). The lower layer was a human
plasma-derived fibrin hydrogel populated with hFBs and the upper
layer was formed by hKCs, seeded confluent on the top of the
plasma-derived fibrin hydrogel. At this point, for clinical use, the bil-
ayered skin substitutes can be transplanted to the patients. After
grafting, the layer of epidermal cells, now in contact with the air, can
proliferate and differentiate to form all the layers of the epidermis,
including the stratum corneum. A very similar process occurs when,
for experimental purposes, human skin substitutes are grafted onto
the back of immunodeficient mice (skin-humanized mice). For in vitro
studies, the terminal differentiation of the epidermis is achieved by
placing the culture in transwell inserts at the air–liquid surface for
17 days.
Although fibroblast-mediated matrix contraction is a parameter
frequently used to examine fibroblast function, activity, and fate
(Chen et al., 2005; Darby, Zakuan, Billet, & Desmouliere, 2016;
Ferrer-Mayorga et al., 2017; Javelaud, Laboureau, Gabison,
Verrecchia, & Mauviel, 2003; Kopp et al., 2005; Li & Wang, 2011;
Tracy, Minasian, & Caterson, 2016; Wynn & Ramalingam, 2012; Yang
et al., 2015), it constitutes a relevant limitation for the standardization
of bilayered skin substitutes and their reliable application. This fibro-
blast-mediated contraction, in the case of skin cultures based on colla-
gen and fibrin hydrogels, results in constructs that either lack
attachment to the culture insert wall and/or suffer shrinking in the z-
axis (Bell, Ivarsson, & Merrill, 1979; Meana et al., 1998). Furthermore,
skin substitutes present these phenomena even during manipulation,
transport, or implantation, which can complicate their clinical use
(Campbell, Bennett, Driscoll, & Sawhney, 2005; Carriel et al., 2012;
Haugh, Thorpe, Vinardell, Buckley, & Kelly, 2012; Tuan, Song, Chang,
Younai, & Nimni, 1996). In addition, plasma-derived fibrin hydrogels
low stiffness makes difficult their surgical handling (Haisch, Klaring,
Groger, Gebert, & Sittinger, 2002; Ruszymah, Chua, Mazlyzam, &
Aminuddin, 2011).
Several attempts such as physical modification, anchoring the
hydrogels, caging in solid scaffolds, chemical modification or even
introducing other synthetic or natural polymers, have been made to
overcome the contractility of collagen and fibrin hydrogels in skin tis-
sue engineering (Braziulis et al., 2012; Burmeister et al., 2016;
Burmeister, Roy, Becerra, Natesan, & Christy, 2018; Lotz et al., 2017;
Mandrycky, Wang, Kim, & Kim, 2016; Monaghan, Browne, Schenke-
Layland, & Pandit, 2014; Mori, Morimoto, & Takeuchi, 2017; Natesan
et al., 2019; Sriram et al., 2018; Stone, Wall, Natesan, & Christy, 2018).
In all these studies, it was considered that fibroblasts-mediated matrix
contraction is the main component of this phenomenon (de Jesus &
Sander, 2014; Freyman, Yannas, Yokoo, & Gibson, 2001;
Grinnell, 2000; Jansen, Bacabac, Piechocka, & Koenderink, 2013;
Tuan et al., 1996; Zhu et al., 2001). However, the possibility that the
collagen and fibrin matrices present an intrinsic, fibroblast-indepen-
dent contraction has been poorly investigated (Zhang, Xu, Wei, Zhai,
& Li, 2013; Zhao et al., 2008).
Therefore, further characterization of the fibrin matrix is required
to fully understand its behavior and discern the reason behind this
excessive contraction, which hinders the usefulness of fibrin-based
bilayered skin substitutes.
To this aim, we first studied the effect of different temperatures
(4C [storage temperature], 23C [room temperature], and 37C [tis-
sue culture temperature]) on the contraction (mass loss), porosity,
morphological structure, and mechanical properties of plasma-derived
fibrin matrices free-floating in a commonly used isotonic buffer (phos-
phate-buffered saline [PBS]), using commercial fibrinogen hydrogels
as controls. Then, to get closer to tissue culture conditions, the effect
of the culture medium (Dulbecco's modified eagle medium [DMEM]
supplemented with 10% fetal bovine serum [FBS] at 37C) on the
contraction (mass loss) of free-floating plasma-derived fibrin hydrogels
was analyzed.
Finally, the contraction of the bilayered skin substitutes was stud-
ied under their standard culture conditions, that is, within a transwell
in which they remain attached to the walls and containing hFBs
embedded in the dermal matrix (the plasma-derived fibrin hydrogel)
and hKCs on its surface. The results of all these experiments
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demonstrate that there is an intrinsic contraction due to the plasma-
derived fibrin matrix itself, which under our experimental conditions is
similar in magnitude to the contraction due to the cells, and that this
effect has to be taken into account when using bilayered skin
substitutes.
2 | MATERIALS AND METHODS
2.1 | Materials
Fresh frozen human platelet-poor plasma was provided by a local
blood bank (Banco de Sangre del Centro Comunitario de Transfusión
del Principado de Asturias [CCST], Spain) and were obtained
according to the standards of the American Association of Blood
Banks (Walker, 1993). For conservation purposes, plasma batches
were aliquoted and stored at −20C (Brecher, 2005; Insenser, Marti-
nez-Garcia, Nieto, San-Millan, & Escobar-Morreale, 2010; Pinto
et al., 2014). Commercial fibrinogen from human plasma was obtained
from Sigma Aldrich and was stored at −20C. Thrombin was obtained
as a raw material from Sigma Aldrich, and was stored at −20C Each
vial contained 10 National Institute of Health (NIH) units of thrombin
approximately. Calcium chloride (CaCl2), sodium chloride (NaCl), PBS,
and bovine serum albumin (BSA) were purchased from Sigma Aldrich.
Amchafibrin (Rottafarm, Spain) was used as an antifibrinolytic agent.
The Bio-Rad Protein Assay Dye Reagent Concentrate (Bio-Rad) was
used for the Bradford assays.
2.2 | Preparation of plasma- and commercial
fibrinogen-derived fibrin hydrogels
Plasma-derived fibrin hydrogels were prepared following the proto-
col described by Meana et al. (1998). The experiments described in
this article were performed using plasma from the same batch.
Plasma aliquots of known fibrinogen concentration were thawed in a
water bath at 37C. In a typical experiment, to prepare 0.813 ml of
plasma hydrogel in a glass vial, 400 μl of plasma (with a fibrinogen
concentration of 2.44 mg/ml) 6.5 μl of Amchafibrin, 341.5 μl of
saline (NaCl 0.9% [wt/vol]), and 65 μl of CaCl2 (prepared at 1% wt/
vol in saline) were sequentially added to the vial and mixed. The final
concentrations of fibrinogen and CaCl2 in the plasma hydrogels were
adjusted to 0.12 and 0.08% (wt/vol), respectively, by conveniently
varying the plasma and saline volumes used. The solution was kept
inside an incubator at 37C and 5% CO2 for 1 hr to allow the gela-
tion reaction to occur.
Commercial fibrinogen-derived fibrin hydrogels having the same
final concentration of fibrinogen than plasma-derived hydrogels
(1.2 mg/ml), were prepared as follows Commercial fibrinogen was dis-
solved in saline at 5.2 mg/ml by vortexing. To prepare the thrombin
solution, 1 ml of saline was added to each vial (containing 10 NIH
units of thrombin). The amount of thrombin needed to prepare the
hydrogels was determined taking into account (Fischer, Ruf, &
Mueller, 1995; Gaffney & Edgell, 1995) that there are from 2 to
5 nmol (of thrombin in human plasma, and that one NIH unit of
thrombin is equivalent to 0.324 ± 0.073 μg of thrombin. In a typical
experiment, to prepare a volume of 1.626 ml of commercial fibrinogen
hydrogel in a glass vial, the following components were added consec-
utively: 1063.25 μl of saline, 130 μl of CaCl2 [prepared at 1% wt/vol
in saline]) (final concentration 0.08% wt/wt), 44.75 μl of thrombin pre-
pared as described above, 13 μl of Amchafibrin, and finally 375 μl of
previously prepared fibrinogen (0.12% wt/wt final concentration).
Once the fibrinogen was added and mixed with the other reagents,
the vial was closed, and placed into an incubator at 37C, 5% CO2,
and 40% relative humidity for 1 hour.
2.3 | Gelation time and kinetics
Plasma- and commercial fibrinogen-derived fibrin hydrogel gelation
times were determined first using the flip-flop method. This method is
based on the free flowing of liquid inside the vials where hydrogels
were prepared. The hydrogel mixtures were prepared and incubated
as above described. Vials were then tilted every 30 s. The time when
there was no liquid left in the vial and the hydrogel remained stuck at
the bottom was considered as the gelation time. Hydrogel gelation
was also determined by turbidimetry and monitored using a Syn-
ergyTM HTX Multi-Mode Microplate Reader (Winooski, VT). (La First,
to determine the most adequate wavelength to study the sol–gel tran-
sition. To this, absorbance was measured from 200 to 800 nm, in
5 nm steps, at 37C. Two different samples were compared. (a) a
homogenized solution of plasma, Amchafibrin, NaCl, and CaCl2 with
the concentrations described in Section 2.2, that will eventually reach
the gel state and display an increase of absorbance, and (b) the same
solution without CaCl2, which will not gelate. A similar procedure was
followed for commercial fibrinogen hydrogels. Once the optimal
wavelength was determined, in the microplate reader for 1 hr, at
37C, in 30 s intervals for the plasma hydrogels and 5 s intervals for
the commercial fibrinogen hydrogels.
2.4 | Contraction of hydrogels in PBS at different
temperatures
The contraction of the hydrogels was assessed by mass loss. Plasma
and commercial fibrinogen hydrogels were prepared in glass vials,
detached by adding 2 ml of PBS at 37C, placed into 60 × 15 mm2
Petri dishes (Fisher Scientific) and submerged in a total volume of 7 ml
of PBS at different temperatures (4, 23, and 37C). At each time point,
PBS was removed, the dishes carefully dried and the hydrogels
weighted in a precision scale balance. Afterward, 7 ml of fresh PBS
were pipetted into the dish at the desired temperature and the dishes
were incubated at the desired temperature until the next time point.
Weight measurements were performed at 1, 2, 4, 6, 8, 24, 48, and
72 hr, and 5, 7, 10, 15, 21, and 30 days. The following equation was
used to calculate the mass-swelling ratio:





where SRw is the mass swelling ratio, Mi is the mass of the hydrogel at
each time point, andMo is the mass of the hydrogel at time zero.
2.5 | Degradation assay of fibrinogen hydrogels
Commercial fibrinogen hydrogels degradation was assessed in PBS at
37C by measuring the weight of the lyophilized hydrogels at differ-
ent time points. Three hydrogels per time point were prepared as
explained in Section 2.2 with a final volume of 1.5 ml per gel. Samples
were detached from the glass vials and incubated in 7 ml of PBS at
37C for 0, 1, 7, 14, and 21 days (in Petri dishes). At each time, hydro-
gels were removed from the incubator and freeze dried in a
LABCONCO freeze dryer. Dried hydrogels were weighted twice in
p35 dishes. Results were expressed as final dried weight in milligrams.
2.6 | Amount of cumulative protein released from
hydrogels
The Bio-Rad Protein Assay Dye Reagent Concentrate was used to
determine the amount of cumulative proteins released from plasma
and commercial fibrinogen hydrogels at the temperatures and time
points used in the contraction studies (Section 2.4) described by Brad-
ford (Bradford, 1976) and using BSA in PBS for the calibration curve
(Zor & Selinger, 1996).
To determine the amount of protein released from the hydrogels,
media was removed from the corresponding Petri dish, and 5 μl of col-
lected media was mixed with 795 μl of PBS and 200 μl of Bradford
reagent and the absorbance read in the spectrophotometer at
595 nm. Solution was periodically collected for its analysis and then
replaced by the same volume of fresh media for the rest of the time
points.
2.7 | Characterization of hydrogel structure
Plasma and commercial fibrinogen hydrogels were structurally charac-
terized through scanning electron microscopy (SEM). In order to main-
tain its internal morphology, samples were subjected to supercritical
CO2 point drying reported elsewhere (Cohen, 1979; Niederman,
Amrein, & Hartwig, 1983; Syverud, Kirsebom, Hajizadeh, & Chinga-
Carrasco, 2011). Plasma and commercial fibrinogen hydrogels at Time
0 were prepared and detached from the glass vials with distilled water
(dH2O) at 37C after 1 hr of incubation at 37C and 5% CO2. Plasma
hydrogels kept in PBS for 48 hr at 4C and for 7 days at 37C, were
also analyzed. Hydrogels were dehydrated by sequential incubations
in ethanol/water solutions according to the following procedure:
hydrogels were first introduced in 20% ethanol for 2 hr. After this
time, they were immersed in 40% ethanol for 2 hr and then left
overnight in 60% ethanol. Two more exchanges were made the next
day: immersion in 80% ethanol for 2 hr and then in 100% ethanol for
the same time. Finally, hydrogels were stored overnight in 100% etha-
nol at 100% vol/vol and then transferred to p35 dishes.
Prior to characterization of the structure of the hydrogels by
SEM, they subjected to CO2 supercritical drying by placing them into
a supercritical reactor Thar R100W and gradually replacing ethanol
with CO2. Subsequently, the temperature and the pressure of the sys-
tem were raised during 10 min from 23C and 60 bar to 35C and
100 bars (supercritical point of CO2 is 31C and 73.96 bar) and left
for 90 min under CO2 supercritical conditions using a 5 g/min CO2
flow. Then, the system was slowly depressurized to room temperature
and atmospheric pressure during 20 min. Once dried, gels were
immersed in liquid nitrogen to facilitate sectioning. Samples were
fixed in the substrate and then sputter coating was performed. Sam-
ples were coated for 75 s with gold by using Leica EM ACE600 to
minimize possible damage to the specimens and to improve topo-
graphical contrast for better SEM analysis. The dehydrated gels were
imaged using a Philips XL30 SEM.
2.8 | Rheological measurements
The rheological characterization of plasma-derived hydrogels was per-
formed in a TA Instruments AR-G2 Rheometer (New Castle) using a
sand-blasted aluminum plate (25 mm diameter). Disc-shaped gel sam-
ples were placed between the parallel plates and the gap between the
plates was adjusted applying the minimum normal force to prevent
slippage. A gap higher than 1,000 μm was always reached after the
sample relaxed until equilibrium. Measurements were performed on
plasma-derived hydrogels immersed in PBS for 0, 2, and 7 days at 4,
23, and 37C, with the sample temperature being controlled and
maintained using a Peltier device.
First, the storage modulus (G0) and the loss modulus (G00) were
measured as a function of strain by an oscillatory strain sweep with
amplitudes ranging between 0.01 and 200% and at a frequency of
0.3 Hz. These measurements were performed to determine the range
of strain amplitudes over which the gels exhibited a linear region of
viscoelasticity. A second measurement consisted of the dynamic fre-
quency sweep between 0.01 and 10 Hz at a fixed strain, selected
within the hydrogel linear region with the aim of obtaining the depen-
dence of G0 and G00 with frequency.
2.9 | Comparison of the contraction of plasma-
derived fibrin hydrogel in PBS and DMEM plus 10%
FBS at 37C
Mass swelling was used to study the contractile behavior of hydrogels
at 37C in PBS and in supplemented cell culture medium (DMEM/
10% FBS). Plasma hydrogels were prepared in glass vials and incu-
bated at 37C for 1 hr for gelation. Afterward, gels were removed
from the vials as previously stated, poured into preweighted p35
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dishes, weighted in a precision balance, and returned to PBS or
DMEM/10% FBS at 37C. Subsequent weight measurements were
performed 2, 4, 6, 8, 24, 48, and 72 hr, 5, 7, 10, 15, 21, and 30 days.
The mass swelling ratio was calculated using Equation (1)
(Section 2.4).
2.10 | Primary hKCs and hFBs culture
hFBs and hKCs obtained from skin biopsies of healthy donors were
obtained from the collections of biological samples of human origin
registered in the “Registro Nacional de Biobancos para Investigación
Biomédica del Instituto de Salud Carlos III.” In this work, we have used
cells from a single donor. hKCs were cultured following previously
described methods (Rheinwatd & Green, 1975) as modified by our
laboratory (del Rio et al., 2002; Meana et al., 1998). The growing
medium for hKCs was a 3:1 mixture of DMEM (GIBCO-BRL) and
HAM'S F12 (GIBCO-BRL) (hKC medium) containing 10% of FBS,
0.1 nM choleric toxin, 2 nM T3, 5 mg ml−1 insulin, 0.4 mg ml−1 hydro-
cortisone, and 10 ng ml−1 EGF (Sigma, St Louis, MO) and Primocyn
1% antibiotic. hFBs were cultured in DMEM (BiochromKG) containing
10% FBS and 1% penicillin/streptomycin.
2.11 | Contraction of plasma-derived fibrin
hydrogels in the z-axis under in vitro skin culture
conditions
Plasma hydrogels were prepared inside transwells in order to generate
dermoepidermal skin constructs in vitro following the protocol previ-
ously reported by Meana et al. (1998). Human primary fibroblasts
were incorporated at a 20,000 cells/ml density and hydrogels were
left incubating for 1 hr. Human primary keratinocytes were later
seeded after 24 hr on top of the plasma hydrogels at a density of 1.5
million cells in 1 ml. Keratinocytes were left to sink and attach to the
hydrogels surface for 48 hr before transferring the whole system into
deep-well plates. Medium was then removed from the top of tran-
swells in order for the keratinocyte differentiation to start in contact
with the air. This air liquid interface served as the system to generate
organotypic skin constructs.
For comparison, we studied the contraction of plasma hydrogels
without cells under similar conditions. Photographs were taken of the
profile of the transwells in the presence of a ruler that acted as scale
for the measurement of the height of the hydrogels during the differ-
entiation process. Defined time points were 0 hr, 4 hr, 6 hr, 8 hr,
24 hr, 48 hr, 72 hr, 7 days, 10 days, 15 days, and 21 days. Images
were analyzed with the ImageJ software.
2.12 | Statistical analysis
Experiments were performed in triplicates unless otherwise specified
in the figure legends. Data are expressed as means ± SD. Statistical
analysis was performed using the IBM SPPS software. Student's t test
(Student, 1908) was used to determine the statistical significance of
result differences. Three levels of significance were assessed: *p < .05;
**p < .01; ***p < .001.
3 | RESULTS
3.1 | Gelation kinetics
Hydrogel gelation time was studied using the flip-flop method. The
results show a significant difference between the gelation time of
plasma hydrogels (13.4 ± 2.4 min) and commercial fibrinogen hydro-
gels (3.4 ± 0.5 min) (Figure 1a). Characterization of the gelation pro-
cess was further assessed through the study of the polymerization
kinetics by UV spectroscopy. The change in optical density (OD) for
both hydrogel types was dynamically measured every 30 s to accu-
rately determine the kinetics of the polymerization reaction. This is a
common technique used by other groups that have followed the poly-
merization of fibrin hydrogels obtained from both commercial fibrino-
gen (Wedgwood, Freemont, & Tirelli, 2013; Weigandt et al., 2012)
and fibrinogen isolated from human plasma (Zhao et al., 2008). In
order to determine the most adequate wavelength to follow this pro-
cess, we performed UV scans from 200 to 800 nm before and after
gelation.
In the case of commercial fibrinogen, the absorbance difference
between solution and hydrogel was of 1 OD at 350 nm (Figure 1b)
whereas in the case of plasma hydrogels, this difference was of 0.5
OD at 325 nm (Figures 1b and S1). These two wavelengths were then
selected to follow the gelation experiments at 37C. These wave-
lengths fall inside the ones previously reported in the literature that
range between 300 and 550 nm, with lower wavelength being
unsuitable due to potential interference with proteins and DNA
(Turner, McLennan, Bates, & White, 2007). To study the gelation
kinetics, the components for both commercial fibrinogen and plasma
hydrogels were mixed and quickly transferred into the plate reader.
The commercial fibrinogen hydrogels displayed a quick increase of
absorbance, reaching a plateau at around 1 AU after approximately
11 min (Figure 1b). The results for plasma hydrogels were quite differ-
ent, showing a long initial lag phase, in which no change in absorbance
was recorded, followed by a polymerization phase reaching a plateau
at around 0.5 AU after approximately 25 min (Figure 1b).
3.2 | Contraction and protein release studies at
different temperatures
The results corresponding to the contraction studies performed on
plasma-derived and commercial fibrinogen hydrogels are depicted in
Figure 2a,b, respectively. The results obtained for both types of
hydrogels showed that matrices contract after incubation in an aque-
ous environment at the studied temperatures (4, 23, and 37C).
Plasma-derived hydrogels shrank following a similar behavior,
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irrespectively of the temperature (Figure 2a). They presented a rela-
tively rapid contraction of approximately 25% during the first 8 hr
followed by a slower step in which they contract until reaching a pla-
teau of approximately 35% after 10 days.
Fibrinogen hydrogels, used as controls and exposed to the same
temperatures, also presented a deswelling behavior albeit clearly dif-
ferent from that shown by plasma-derived gels (Figure 2b). On the
one hand, they only displayed the more pronounced, first 8 hr step,
On the other hand, they reached quite different contraction values
depending on the temperature, being most dramatic the 70% mass
loss found at 4C. Surprisingly, we did not find a direct correlation
between contraction and temperature.
To find out whether the mass loss displayed by commercial fibrin-
ogen hydrogels was, at least in part, due to degradation, we measured
the weight of hydrogels incubated for different times (1, 7, 14, and
21 days) in PBS at 37C and thereafter lyophilized. Results show that
these hydrogels do not lose any statistically significant weight even
after 21 days under these conditions (Figure 2c). The initial weight of
the hydrogels was slightly below 15 mg and was maintained through-
out the experiments with minor variations.
Bradford assays were performed to obtain a deeper insight into the
deswelling behavior of the plasma-derived hydrogels. A complication
when studying plasma-derived hydrogels is that plasma contains a com-
plex mixture of proteins among which albumin, globulins, and fibrinogen
are the most abundant. While fibrinogen gives rise to the fibrin matrix,
the rest of proteins are entrapped inside the hydrogel and are expected
to be release from it into the surrounding PBS buffer along the time.
The results showed similarly shaped curves of protein release at
the three investigated temperatures (4, 23, and 37C) (Figure 2d). The
three curves reached a plateau at approximately 48 hr although, as
could be expected, both the amount of released protein and the initial
slope of the curves increased with increasing temperature. In agree-
ment with the data shown in Figure 2d, commercial fibrinogen hydro-
gels failed to show any protein release. Knowing the initial volume of
human plasma used to prepare the plasma-derived hydrogels and the
published concentration of total protein present in plasma
(Arnaud, 2004; Buis et al., 1996), we estimate that our gels contain ini-
tially 25 mg of proteins. Therefore, we were able to determine the
percentage of plasma proteins released from the hydrogels incubated
at the different temperatures (4C: 15 mg, 60%; 23C: 20 mg, 80%;
and 37C: 22.5 mg, 90%) after 30 days. As Figure 2d shows, commer-
cial fibrinogen hydrogels do not present any protein release detect-
able by this assay.
Statistically significant differences were found at 48 hr (the pla-
teau of the curves) when comparing the protein release values at 4
and 23C (p < .001) and when comparing at the same time point the
values at 4, 23, and 37C (p < .01. In parallel experiments to those
described, the evolution of plasma-derived hydrogels at 4C was visu-
ally observed and photographed at different time points (Figure 2e).
They presented a progressive decrease in size and a change in color,
from an initial yellow color to a final pale, semitransparent one. These
changes are coherent with the contraction and protein release data of
Figure 2a,d, respectively. Furthermore, polyacrylamide gel electropho-
resis corroborated the Bradford assay results (Figure S2).
F IGURE 1 (a) Gelation time at
37C for commercial fibrinogen (left)
and plasma hydrogels (right) using the
flip-flop method. (b) Gelation kinetics
for commercial fibrinogen and plasma
hydrogels using UV spectrometry at
325 and 350 nm, respectively. Data
expressed as mean ± SD, n = 8
MONTERO ET AL. 505
3.3 | Morphological characterization by SEM
Comparison of Figure 3a,d demonstrates clear structural differ-
ences between untreated plasma-derived and commercial fibrino-
gen hydrogels. Whereas the later display smooth, tangled, and
clearly delineated fibers with a diameter of 94 ± 19.08 nm (Fig-
ure S4), the former's fibers are stiffer, irregular, and thicker
(280 ± 47.53 nm in diameter). No differences in fiber thickness nor
porous structure was found between the plasma hydrogels after
7 days at 37C and the initial commercial fibrinogen hydrogels (Fig-
ure 3c,d). Finally, plasma-derived hydrogels treated for 48 hr at 4C
present an intricate structure, somewhat reminiscent of that of
untreated samples but more irregular, and with less defined fibers
(Figure 2b).
3.4 | Rheological characterization
Rheological experiments were designed to understand the perfor-
mance of the hydrogels at different temperatures (4, 23, and 37C) in
terms of shear forces and Representative results corresponding to
strain sweep tests were carried out on untreated plasma-derived
hydrogels (control gels, 0 hr), and plasma-derived hydrogels
maintained at different temperatures during 48 hr (Figure 4a). As a
F IGURE 2 (a) Plasma hydrogels contraction, measured as mass loss, in PBS at 4, 23, and 37C. (b) Commercial fibrinogen hydrogels
contraction, measured as mass loss, in PBS at 4, 23, and 37C. The plateau values at 48 hr are statistically significantly different (p < .01). (c)
Commercial fibrinogen hydrogel degradation assay for 21 days in phosphate-buffered saline (PBS) at 37C. (d) Cumulative protein release for
hydrogels incubated at 4, 23, and 37C as measured by the Bradford assay. (e) Representative plasma-derived hydrogels incubated at 4C in PBS
for different times: 0 hr, 4 hr, 24 hr, and 10 days, showing the shrinkage, loss of color, and increased transparency that they experiment. Data are
expressed as mean ± SD, n = 4. Scale bar = 1 cm
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general behavior, all samples present G0 (elastic modulus) > G00 (viscous
modulus) up to a critical deformation, γ0, estimated as the point where the
slope of the stress–strain curves change dramatically and G0 and G" rapidly
decrease with increasing strain, causing the nonlinearity γ0 represents the
minimum strain needed to induce flow, and the crossover point between
G0 and G00 indicates the change from a solid-like to a liquid like behavior.
Focusing on the evolution of G0 with strain, none of the samples present
strain-hardening behavior, that is an increase of G0 with strain.
Focusing on the evolution of G00 with strain, it is observed that all
the samples present a constant value of G00 up to a value of strain here
G00 starts to increase giving rise to a maximum, followed again by a
decrease (Figure 4a) A representation of G00 as a function of tempera-
ture obtained for plasma-derived hydrogels after 48 hr and 7 days is
shown in Figure 4b. Regardless the treatment time (48 hr or 7 days)
G00max decreases with temperature being the values obtained for G00max
for gels after 48 hr higher than the values obtained for G00 for gels
after 7 days of treatment. In order to get further insight on the effect
of temperature and time of incubation on the elastic properties of the
hydrogels, G0 and G00 were measured as a function of frequency. The
results corresponding to hydrogels maintained at different tempera-
tures for 48 hr are depicted in Figure 4c. All the samples present gel-
like behavior which is characterized by (a) values of the elastic modu-
lus higher than the corresponding to the viscous modulus (G0 > G00) in
the frequency range studied and (b) G0 and G00 are independent of fre-
quency in the studied frequency range.
The values of the moduli measured at a frequency of 0.3 Hz were
analyzed for s plasma-derived hydrogels incubated at 4, 23, and 37C
during 48 hr. As Figure 4c shows, these moduli do not change appre-
ciably with temperature. In contrast, the elastic moduli measured after
7 days of treatment show significantly different results. For all studied
temperatures, the elastic moduli decrease with respect to the control
gel (0 hr) except for the gel maintained at 4C for which the elastic
moduli remain unaffected by the thermal treatment (Figure 4d).
3.5 | Comparison of the contraction of plasma-
derived fibrin hydrogels in PBS and DMEM plus10%
FBS at 37C
To analyze their swelling behavior under situations similar to those
found in tissue culture, plasma-derived hydrogels were incubated
at 37C in PBS (as a control) and in supplemented culture medium
(DMEM plus 10% FBS) for 30 days. It was found (Figure 5a) that,
as expected, PBS control hydrogels showed a deswelling (mea-
sured as mass loss) kinetics very similar to that already described
under similar conditions (see Figure 2a), characterized by a rapid
F IGURE 3 Scanning electron microscope (SEM) images of untreated plasma hydrogels (at 0 hr) (a); plasma-derived hydrogels treated for 48 hr
in phosphate-buffered saline (PBS) at 4C (b); plasma-derived hydrogels treated for 7 days in PBS at 37C (c); and untreated commercial
fibrinogen hydrogels (at 0 hr) (d)
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first phase of contraction (approximately 30% mass loss) during
the first 8–24 hr followed by a slow contraction phase (approxi-
mately 40% mass loss after 30 days). However, hydrogels incu-
bated in supplemented culture medium only suffered the first,
rapid contraction step. The two deswelling curves presented sta-
tistically significant differences, at least at the longer times (for
instance, p < .05 at 21 days).
3.6 | Contraction of plasma-derived fibrin
hydrogels in the z-axis under in vitro skin culture
conditions
Until now, in this article, we have analyzed the behavior of acellular,
free-floating hydrogels, either in glass vials or in Petri dishes. Now we
want to study them under fully in vitro skin culture conditions, that is,
F IGURE 4 (a) Strain sweep test of plasma-derived hydrogels at different temperatures (4, 23, and 37C) after 48 hr of incubation and control
(plasma hydrogels at 0 hr). G0 closed symbols, G00 open symbols. (b) Representation of G00max obtained from strain sweep tests of plasma-derived
fibrin gels incubated at different temperatures for 48 hr (▪) and 7 days (▪). Dashed lines are a guide for the eye. (c) Frequency sweep test. Samples
are as in (a). Elastic moduli for hydrogels maintained at different temperatures (4, 23, and 37C) for 48 hr and 7 days. For comparison, the elastic
modulus corresponding to plasma-derived hydrogels at 0 hr of incubation is also shown. Data expressed as mean ± SD, n = 3
F IGURE 5 (a) Hydrogel
contraction measured as mass loss
comparing plasma-derived hydrogels
incubated in phosphate-buffered
saline (PBS) or in supplemented cell
culture medium (Dulbecco's modified
eagle medium (DMEM]
supplemented with 10% fetal bovine
serum [FBS]) at 37C. (b) Plasma-
derived fibrin hydrogels free-floating
in PBS and DMEM plus 10% FBS at
24 hr where the changes in weight
were measured. Data expressed as
mean ± SD. n = 3
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at 37C, in supplemented DMEM cell culture medium, containing cells
and inside transwell inserts. Under these conditions, fibrin-derived
hydrogels do not detach from the transwell walls and contraction is
manifested as a decrease in gel height. To this, plasma-derived hydro-
gels, with and without skin cells, were prepared in transwell inserts
following the standard in vitro skin equivalent generation protocol
described in Section 2.11, and their height was measured using
ImageJ software. Interestingly, the z-axis hydrogel contraction during
the initial 24 hr was very similar regardless of the presence of hFBS
(Figure 6a). After the initial 24 hr, the effect of the cells contracting
the matrix becomes apparent, making the hydrogels containing hFBs
and hKCs to contract up to 70% after 21 days.
4 | DISCUSSION
In order to improve the usefulness of fibrin-based hydrogels and try
to find ways to overcome some of their current drawbacks, in particu-
lar the contraction they experiment with time, in this work we have
analyzed relevant processes that take place during their in vitro pro-
duction and experimental and clinical use. We are particularly inter-
ested in fibrin hydrogels generated from human blood plasma because
they contain a complex mixture of proteins and lipids entrapped in the
fibrin matrix, which are known to be relevant for wound healing and,
in particular, for cell proliferation and migration. Given that this com-
plexity greatly complicates their analysis, we have used commercial
fibrinogen-based hydrogels as controls to try to discern the cause of
the observed results.
Regarding gelation, the two types of hydrogels behaved quite dif-
ferently. For instance, commercial fibrinogen gels polymerized quicker
and were quite fragile likely due, at least in part, to its very low fibrin-
ogen concentration (1.2 mg/ml, to match the fibrinogen concentration
used in the plasma-derived hydrogels) as compared to the concentra-
tions usually reported in the literature (10–20 mg/ml). On the con-
trary, the proteins and lipids trapped in plasma-derived hydrogels
provide them with mechanical stability and induce delayed gelation
time probably due to steric effects (Arnaud, 2004).
To determine gelation time and kinetics, two frequently used
methods, flip-flop and optical absorbance (turbidimetry), were
followed. The first one is very quick and easy to perform but it gives
information about whether the gels had formed just based on visual
inspection. Even so, it indicated that commercial fibrinogen gels poly-
merize in a much shorter time (about 3.5 min) than plasma-based gels
(about 13.5 min) (Figure 1a). These times are manifestly shorter than
those measured by turbidimetric assays (Figure 1b), indicating that
polymerization was far from completed. This last technique, based on
light absorbance related to fibril formation, fibril structure, and fibril–
fibril interactions (Kreger et al., 2010) provides quantified parameters
such as kinetics shape, lag time, half-time, and final absorbance.
As seen in Figure 1b, according to this technique, the two types of
hydrogels follow very different polymerization kinetics, both qualitatively
(e.g., lag time and shape of polymerization curves) and quantitatively (e.g.,
F IGURE 6 (a) Hydrogels
contraction in the z-axis in the
presence and absence of human
fibroblasts (hFBs) and
keratinocytes (hKCs), incubated in
Dulbecco's modified eagle medium
(DMEM) supplemented with 10%
fetal bovine serum (FBS) during
21 days. (b) Photograph of the
culture system. (c) Scheme
showing the different phases of
the in vitro generation of a skin
substitutes (plasma gels with hFB
and hKC): (1) Human plasma-
derived fibrin hydrogels containing
embedded hFBs are generated in
transwell inserts. (2) After 24 hr,
hKCs are seeded at confluency on
top of the hydrogels. (3) After
additional 48 hr, the culture is
placed at the air–liquid interface.
(4) Full epidermal differentiation is
achieved after 17 days of culture
at the liquid–air interface. Data in
(a) are expressed as
mean ± SD. n = 3
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polymerization rate and final absorbance). Besides potential differences in
fibrinogen characteristics related to the different sources of the material,
we attribute these differences to two causes as follows:
1 The already mentioned proteins and lipids entrapped in plasma-
derived hydrogels could be responsible of the larger polymerization
times and lower OD observed in plasma-based gels by steric effects
(Arnaud, 2004) and the color/turbidity they confer to human
plasma (as an indication, see 0 time in Figure 2e), respectively.
2 Although we use physiological amounts of thrombin to induce the
polymerization of commercial fibrinogen gels this thrombin is read-
ily active while the complete coagulation cascade has to be trig-
gered in the case of plasma hydrogels upon calcium addition.
Given that contraction is possibly the main drawback of plasma-
derived fibrin hydrogels, we devoted a good deal of our effort to char-
acterize this phenomenon. Unexpectedly, these gels contracted in an
aqueous medium (PBS) with a similar temporal kinetics over a range
of temperatures (4, 23, and 37C) of experimental and clinical rele-
vance. They showed a bi-phasic deswelling behavior with an initial
quick 25% loss of mass during the first 24 hr followed by a slower
step in which they reach a plateau of approximately 35% mass loss
after 10 days (Figure 2a).
Control commercial fibrinogen hydrogels behaved in a remarkably
different manner. Although they contracted at the studied tempera-
tures, they presented only the first 24 hr deswelling step and they
reached quite different contraction values depending on the tempera-
ture (Figure 2b). Regarding this contraction, Zhao et al. (2008) have
reported a weight loss of 80% after 3 days of incubation in PBS at
37C for commercial fibrinogen hydrogels at different concentrations.
The authors attributed this behavior to fibrinogen dissolution due to
the ionic strength of PBS. However, we do not detect such dissolution
of the fibrinogen hydrogels with time since we do not observe any
protein release in the Bradford assays (Figure 2d) nor weight loss
when they are lyophilized and weighted at different time points (Fig-
ure 2c). Altogether, these data demonstrate that commercial fibrino-
gen hydrogels, at least in our conditions, experience a temperature-
sensitive intrinsic contraction during about 24 hr and suggest that
there must be additional reasons that explain the behavior of plasma-
derived gels.
One of these reasons could be a modulatory effect exerted by
the proteins and lipids embedded in plasma-derived gels. As shown in
Figure 2d, larger amounts of plasma proteins are released from the
gels at higher temperatures during the first 1–3 days of incubation.
On the other hand, as shown in Figure 2b, fibrinogen contraction is
highest at the lowest temperature. These contradictory effects could
equalize the contraction presented by these gels at different tempera-
tures. An alternative, or complementary, explanation could be that
previously reported by Zhang et al. (2013) for collagen hydrogels,
showing an outer hydrophilic and an inner hydrophobic part (Fang,
Chen, Leu, & Hu, 2008; Montero, Valencia, Corrales, Jorcano, &
Velasco, 2019). According to these authors, the aggregation of inter-
molecular assemblies when the hydrogels are submerged in an
aqueous solution might be the mechanism behind contraction. In this
environment, the nonpolar groups attract each other forming new
crosslinking points that make the scaffold to be less porous and thus
release more water to the environment, causing a mass decrease.
However, contrary to what Zhang et al. report, we found that lower
temperatures drove a more drastic contraction for our commercial
fibrinogen model.
SEM analysis (Figure 3) also corroborate that hydrogel structure
and behavior are greatly influenced by the presence/absence of
embedded proteins. They also support the protein release kinetics
data (Figures 2d and S2). So, untreated plasma-based hydrogels (Fig-
ure 3a), containing its full complement of embedded proteins, present
an overall matrix structure and a fiber structure and diameter (Fig-
ure S4) quite different from those of untreated commercial fibrinogen
gels, lacking embedded proteins (Figure 3d). It seems that, under the
SEM sample preparation conditions, the embedded proteins are
adsorbed to, or precipitated around, the fibrin fibers. On the other
hand, plasma-derived hydrogels treated for 7 days at 37C (Figure 3c)
and, therefore predicted to have lost most of their embedded pro-
teins, look very similar to untreated commercial fibrinogen gels.
The rheological study performed at the three defined tempera-
tures showed the absence of what is known as the strain hardening
effect. This effect is defined as the increase of elastic modulus with
strain amplitudes observed above 10% for fibrin hydrogels (Shah &
Janmey, 1997; Storm, Pastore, MacKintosh, Lubensky, &
Janmey, 2005). The molecular origin of the strain hardening seen in
fibrin can be attributed to the rod-like or semiflexible nature of the
fibrin strands in analogy to the polymer network theory of semiflexi-
ble chains (Litvinov & Weisel, 2017). It is generally accepted that the
onset of strain hardening relates to the straightening of these semi-
flexible filaments in the network upon straining and that this phenom-
enon is highly dependent on the structural organization of the fibrin
hydrogel at the level of individual fibers (Li et al., 2016). The fact that
strain-hardening behavior is not observed for plasma-derived hydro-
gels at any of the tested temperatures might again be attributed to
the presence of proteins that alter the morphology and the number of
crosslinking points responsible for the elastic response of the fibrin
hydrogel as seen in the SEM images. This is an analogous result to
that found for plasma clots as compared to pure fibrin hydrogels. In
that case, the presence of platelets eliminated strain hardening in
plasma clots (Shah & Janmey, 1997).
All the samples present a constant value of G00 up to a value of
strain (%) where G00 starts to increase giving rise to a maximum,
followed again by a decrease. This behavior is known as weak-strain
hardening and it is directly related to the energy dissipation due to
the breakage of a gel-like structure. In fibrin clot rheology, energy dis-
sipation may arise from the dissociation of noncovalently linked adja-
cent fibrin monomers and the slippage of protofibrils or fibers
between one another (Ryan, Mockros, Weisel, & Lorand, 1999). The
results found in Figure 4b indicate that temperature increase leads to
diminished levels of energy dissipation during deformation, that is,
plasma-derived hydrogels become more rigid with temperature. These
results might indicate that structural rearrangements between fibers
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or protofibrils become hindered with temperature and immersion time
which could be related to a higher number of crosslinking points. In
order to explain these results, it is necessary to take into account that
lower temperatures favor fibrin polymerization thus leading to a lower
protein release as demonstrated through protein release experiments
(Figure 2d). However, the presence of proteins within plasma-derived
fibrin hydrogels hinder the establishment of interactions between
fibrin fibers resulting in higher times for gel–sol transition and lower
deswelling rates with respect to fibrinogen hydrogels. Hence, the
determinant factor for the observed rheological behavior seems to be
the presence of proteins and the dependence of its release with tem-
perature and time.
From the results obtained in Figure 4c,d, it can be inferred that
the elastic properties of the prepared plasma-derived hydrogel remain
unaltered when these are maintained at 4C, even after 7 days. This is
possibly due to the increased fibrin polymerization at this temperature
and the concomitant presence of proteins nonreleased with a rein-
forcing effect (see Figures 2d and 3b). However, after 7 days, the
plasma-derived fibrin gels present a lower elastic modulus due to the
release of proteins that takes place when the gel is maintained at
T > 23C, as demonstrated in the release profiles shown in Figure 2d,
even if the formation of interactions between fibrin fibers is favored.
Finally, we wanted to understand the behavior of human-derived
fibrin gels under conditions similar to those used in in vitro skin tissue
culture. To this, we first studied gel contraction in DMEM culture
medium supplemented with 10% FBS, at 37C. Under these condi-
tions, plasma hydrogels contracted less than in PBS, as also reported
in (Zhao et al., 2008).
Moreover, of the two deswelling phases repeatedly observed for
these gels in PBS, only the early one, taking place typically during the
initial 8–24 hr was detected. We attribute this change to the presence
of calf serum proteins in the supplemented incubation medium, which
would delay, prevent, or equilibrate the release of human plasma pro-
teins from the fibrin matrix observed in PBS. Additionally, other differ-
ences in composition among DMEM and PBS could alter the
hydrophylic–hydrophobic forces that, as also discussed earlier, could
contribute to fibrin matrix contraction in PBS.
To approach in vitro skin cell culture conditions, plasma-derived
hydrogels, more closely with and without skin cells, were prepared in
transwell inserts as described in Figure 6c. Under these conditions,
fibrin-derived hydrogels do not detach from the transwell walls nor
from their bottom, contraction is manifested as a shrinking of the gel
in the z-axis.
Interestingly, the z-axis hydrogel contraction during the initial
24 hr was very similar regardless the presence of hFBS (Figure 6a).
This effect was also similar to the early contraction displayed as mass
loss by acellular, free-floating plasma-derived gels (Figures 2a and 5a)
and, therefore, contrary to what is widely accepted for the contraction
of fibrin and collagen hydrogels, it cannot be attributed to fibroblasts,
the only cells present in the gels at this early time. This result is also in
agreement with the observation that hFBs no not have time enough
to spread and attach to the fibrin matrix (Miron-Mendoza, Graham,
Manohar, & Petroll, 2017). At longer times, the effect of hFBs and
HKCs on the z-axis shrinkage becomes apparent, reaching very high
values (up to 70% after 21 days) that limit the time span of the cul-
ture. We attribute this strong effect to cell-mediated contraction of
the fibrin matrix together with matrix degradation by proteases syn-
thesized by skin cells, such as matrix metalloproteinases. These
enzymes are known to play important roles in proteolytic remodeling
of ECM in various physiologic situations, including skin tissue repair
and aging (Kähäri & Saarialho-Kere, 1997; Pittayapruek, Meephansan,
Prapapan, Komine, & Ohtsuki, 2016).
5 | CONCLUSIONS
In this work, we have carefully analyzed the structure, rheological
properties and behavior of plasma-derived fibrin hydrogels under dif-
ferent experimentally relevant conditions. The main aim was to delve
into the causes behind the contraction that these gels experience over
time, which is their main drawback and prevents a more widespread
experimental and clinical use in wound healing and skin tissue engi-
neering. Aware that the complex composition of human plasma would
complicate these studies, we used commercial fibrinogen-based gels
as controls.
The contractile behavior can be explained by the intrinsic ten-
dency displayed by fibrin hydrogels to deswell in aqueous solution.
This process is relatively quick and strongly dependent on tempera-
ture and can be very dramatic (e.g., 70% mass loss after 8 hr at 4C)
for commercial fibrinogen-based fibrin gels. In the case of plasma-
derived gels, the process is slowed down and milder (35% contraction
after 10 days), and, surprisingly, temperature-independent between 4
and 37C. We attribute this notorious change of behavior mainly to
the progressive release to the incubation medium (PBS) of plasma pro-
teins and lipids initially entrapped in the fibrin matrix, although remo-
deling of the fibrin matrix provoked by changes in hydrophilic/
hydrophobic interactions arising when the hydrogels are submerged
in an aqueous solution could also be at play. In addition, this progres-
sive depletion of plasma components from the fibrin gels seems to be
involved in the changes that we observed in several parameters (e.g.,
pore size, fibrin fiber diameter, porosity, and rheological parameters)
when incubating plasma-derived fibrin hydrogels at different tempera-
tures for different times. These three mechanisms, namely, intrinsic
fibrin matrix contraction, progressive depletion of plasma compo-
nents, and changes in hydrophilic/hydrophobic forces, are also pre-
sent in plasma-derived fibrin gels under conditions used for skin tissue
culture. Together with additional matrix contraction and degradation
due to the skin cells present in the culture, they lead to an excessive
fibrin matrix reduction (70% after 21 days in culture) that limits the
usefulness of this skin tissue culture technique that clearly needs
design improvements.
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